{"text_format":"2","workbook":"xls","n_sheets":3,"sheets":["Sheet1","Sheet2","Sheet3"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet1","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}
["Table S4: Topological parameters of potential drug target proteins"]
[]
["Symbol ID","Betweenness centrality","Rank (Betweenness centrality)","Degree","Rank (Degree)"]
["CD28",0.00037686,439,32,169]
["CD4",0.00388769,101,67,46]
["CD8A",0.00159438,202,50,89]
["CTLA4",0.0003363,466,23,248]
["EGFR",0.01505606,22,96,20]
["EPOR",0.001397,214,28,192]
["IGF1R",0.00212948,158,39,124]
["IL2RA",0.00104,262,45,106]
["IL4R",0.00018863,575,23,248]
["ITGAV",0.00219193,151,38,129]
["KDR",0.00216444,155,42,116]
["KIT",0.00036893,446,28,202]
["MET",0.00160652,199,38,129]
["NGFR",0.00105032,259,27,204]
["PDGFRB",0.00189349,174,38,129]
["TGFBR1",0.0010265,269,25,220]
["TLR4",0.00200197,166,50,89]

{"sheet":"Sheet2","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}

{"sheet":"Sheet3","index":2,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[],"flags":["formulas_cached_only"]}